FDA Inspection 1003878 — Seaway Pharma Inc.

Seaway Pharma Inc. — FEI 3012275336

The FDA completed an inspection of Seaway Pharma Inc. on Mar 1, 2017 in Massena, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 1, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Massena, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.